about
B cells as a therapeutic target in autoimmune diseaseSLE - Rituximab in lupusRituximab in the treatment of autoimmune haematological disorders.Therapeutic apheresis in autoimmune diseases.Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA studyConsensus statement on the use of rituximab in patients with rheumatoid arthritisRituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.The role of B cells in systemic sclerosis.Potential applications of designed ankyrin repeat proteins in diagnostics and therapeutics.Targeting B cells in treatment of autoimmunity.Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis.Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus.Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, mulThe impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
P2860
Q24804504-6BC6D78C-A038-4581-B86A-46C234DA295EQ24804739-47574EA9-73C1-4EA6-ABDD-2559D7727F1FQ33378854-2F436F63-6B28-498D-B1E6-47DD7AEE911EQ33436347-9C3818B2-0D1D-4532-BD90-38A11EA57AA4Q33909097-55AC2C19-9E7E-4C7F-89B5-289FA126ED6BQ35555456-D2482D91-79E6-4494-A890-891FDDFA14F7Q35638676-3FFC4C7E-5323-4ACA-86A7-9AE19318E15BQ36460981-0A88932B-07EB-451C-9E03-FC95258E5BE7Q37586886-2B28246B-A034-46D0-AEEE-7620F6D5DA4DQ38089263-207B7E74-4066-4D32-A5D8-3469F8DF7514Q38975656-51CC2D9A-97B5-4CD1-834F-7A32FC09D629Q39938037-28ABB5C9-D94D-4D2D-9EBB-2A15B2E86E06Q40523209-6B3C1B15-4D64-45B7-86BE-1BCA5B3A7266Q44470266-22D12301-2BA3-4453-A056-B0A9736D2B50Q46504507-A8E91F5D-1AF0-40F8-8E61-F32D2BC2C3FBQ48337788-BE045624-5F7C-4870-8EC4-87C8BAC91751Q55228908-E49E13D6-A02F-4400-BF17-9386758EAA41
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treating human autoimmune disease by depleting B cells
@ast
Treating human autoimmune disease by depleting B cells
@en
Treating human autoimmune disease by depleting B cells
@nl
type
label
Treating human autoimmune disease by depleting B cells
@ast
Treating human autoimmune disease by depleting B cells
@en
Treating human autoimmune disease by depleting B cells
@nl
prefLabel
Treating human autoimmune disease by depleting B cells
@ast
Treating human autoimmune disease by depleting B cells
@en
Treating human autoimmune disease by depleting B cells
@nl
P2860
P356
P1476
Treating human autoimmune disease by depleting B cells
@en
P2093
P2860
P304
P356
10.1136/ARD.61.10.863
P407
P577
2002-10-01T00:00:00Z